• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

既往免疫可影响机体对 SARS-CoV-2 加强针疫苗接种和奥密克戎突破性感染风险的免疫应答。

Previous immunity shapes immune responses to SARS-CoV-2 booster vaccination and Omicron breakthrough infection risk.

机构信息

Laboratory of Molecular Medicine, Department of Clinical Immunology, Section 7631, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.

Department of Genetics, Stanford University School of Medicine, Stanford, 94305, CA, USA.

出版信息

Nat Commun. 2023 Sep 12;14(1):5624. doi: 10.1038/s41467-023-41342-2.

DOI:10.1038/s41467-023-41342-2
PMID:37699890
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10497567/
Abstract

The heterogeneity of the SARS-CoV-2 immune responses has become considerably more complex over time and diverse immune imprinting is observed in vaccinated individuals. Despite vaccination, following the emergence of the Omicron variant, some individuals appear more susceptible to primary infections and reinfections than others, underscoring the need to elucidate how immune responses are influenced by previous infections and vaccination. IgG, IgA, neutralizing antibodies and T-cell immune responses in 1,325 individuals (955 of which were infection-naive) were investigated before and after three doses of the BNT162b2 vaccine, examining their relation to breakthrough infections and immune imprinting in the context of Omicron. Our study shows that both humoral and cellular responses following vaccination were generally higher after SARS-CoV-2 infection compared to infection-naive. Notably, viral exposure before vaccination was crucial to achieving a robust IgA response. Individuals with lower IgG, IgA, and neutralizing antibody responses postvaccination had a significantly higher risk of reinfection and future Omicron infections. This was not observed for T-cell responses. A primary infection before Omicron and subsequent reinfection with Omicron dampened the humoral and cellular responses compared to a primary Omicron infection, consistent with immune imprinting. These results underscore the significant impact of hybrid immunity for immune responses in general, particularly for IgA responses even after revaccination, and the importance of robust humoral responses in preventing future infections.

摘要

SARS-CoV-2 免疫反应的异质性随着时间的推移变得更加复杂,并且在接种疫苗的个体中观察到不同的免疫印记。尽管接种了疫苗,但在奥密克戎变异出现后,一些人似乎比其他人更容易受到初次感染和再次感染的影响,这突显出需要阐明先前感染和接种疫苗如何影响免疫反应。在奥密克戎背景下,研究了 1325 个人(其中 955 人无感染史)接种三剂 BNT162b2 疫苗前后的 IgG、IgA、中和抗体和 T 细胞免疫反应,研究了它们与突破性感染和免疫印记的关系。我们的研究表明,与无感染史相比,接种疫苗后体液和细胞反应通常在 SARS-CoV-2 感染后更高。值得注意的是,接种疫苗前的病毒暴露对于实现强大的 IgA 反应至关重要。接种疫苗后 IgG、IgA 和中和抗体反应较低的个体再次感染和未来感染奥密克戎的风险显著增加。这在 T 细胞反应中没有观察到。与初次感染奥密克戎后再次感染奥密克戎相比,奥密克戎之前的初次感染会减弱体液和细胞反应,这与免疫印记一致。这些结果强调了混合免疫对一般免疫反应的重大影响,特别是对 IgA 反应的影响,即使在再次接种疫苗后,以及强大的体液反应在预防未来感染中的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a01/10497567/97ffae7f228d/41467_2023_41342_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a01/10497567/9edd161628dc/41467_2023_41342_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a01/10497567/028a0962684f/41467_2023_41342_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a01/10497567/8fe145814327/41467_2023_41342_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a01/10497567/fd8143ac31f9/41467_2023_41342_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a01/10497567/5219865b95a3/41467_2023_41342_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a01/10497567/462e6de87463/41467_2023_41342_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a01/10497567/c369350afbae/41467_2023_41342_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a01/10497567/9cb3db4bb2ee/41467_2023_41342_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a01/10497567/97ffae7f228d/41467_2023_41342_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a01/10497567/9edd161628dc/41467_2023_41342_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a01/10497567/028a0962684f/41467_2023_41342_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a01/10497567/8fe145814327/41467_2023_41342_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a01/10497567/fd8143ac31f9/41467_2023_41342_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a01/10497567/5219865b95a3/41467_2023_41342_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a01/10497567/462e6de87463/41467_2023_41342_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a01/10497567/c369350afbae/41467_2023_41342_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a01/10497567/9cb3db4bb2ee/41467_2023_41342_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a01/10497567/97ffae7f228d/41467_2023_41342_Fig9_HTML.jpg

相似文献

1
Previous immunity shapes immune responses to SARS-CoV-2 booster vaccination and Omicron breakthrough infection risk.既往免疫可影响机体对 SARS-CoV-2 加强针疫苗接种和奥密克戎突破性感染风险的免疫应答。
Nat Commun. 2023 Sep 12;14(1):5624. doi: 10.1038/s41467-023-41342-2.
2
Correlates of protection and determinants of SARS-CoV-2 breakthrough infections 1 year after third dose vaccination.第三剂接种后 1 年 SARS-CoV-2 突破性感染的保护相关性和决定因素。
BMC Med. 2024 Mar 8;22(1):103. doi: 10.1186/s12916-024-03304-3.
3
SARS-CoV-2 Omicron infection augments the magnitude and durability of systemic and mucosal immunity in triple-dose CoronaVac recipients.奥密克戎变异株感染增强了三剂科兴疫苗接种者的全身性和黏膜免疫的幅度和持久性。
mBio. 2024 Apr 10;15(4):e0240723. doi: 10.1128/mbio.02407-23. Epub 2024 Mar 8.
4
Omicron neutralizing antibody response following booster vaccination compared with breakthrough infection.奥密克戎变异株加强针接种后的中和抗体应答与突破性感染的比较。
Med. 2022 Dec 9;3(12):827-837.e3. doi: 10.1016/j.medj.2022.09.001. Epub 2022 Sep 22.
5
Immune responses in COVID-19 patients during breakthrough infection with SARS-CoV-2 variants Delta, Omicron-BA.1 and Omicron-BA.5.COVID-19 患者在突破感染 SARS-CoV-2 变异株 Delta、Omicron-BA.1 和 Omicron-BA.5 期间的免疫反应。
Front Immunol. 2023 Jul 13;14:1150667. doi: 10.3389/fimmu.2023.1150667. eCollection 2023.
6
Humoral and cellular immunogenicity of homologous and heterologous booster vaccination in Ad26.COV2.S-primed individuals: Comparison by breakthrough infection.同源和异源加强免疫在 Ad26.COV2.S 初免个体中的体液和细胞免疫原性:突破性感染的比较。
Front Immunol. 2023 Mar 7;14:1131229. doi: 10.3389/fimmu.2023.1131229. eCollection 2023.
7
Trends of humoral immune responses to heterologous antigenic exposure due to vaccination & omicron SARS-CoV-2 infection: Implications for boosting.由于疫苗接种和奥密克戎 SARS-CoV-2 感染导致的针对异源抗原暴露的体液免疫反应趋势:对增强作用的影响。
Indian J Med Res. 2023 Jun;157(6):509-518. doi: 10.4103/ijmr.ijmr_2521_22.
8
Sequence Matters: Primary COVID-19 Vaccination after Infection Elicits Similar Anti-spike Antibody Levels, but Stronger Antibody Dependent Cell-mediated Cytotoxicity than Breakthrough Infection.序列很重要:感染后进行初级 COVID-19 疫苗接种会引起相似的刺突抗体水平,但比突破性感染产生更强的抗体依赖的细胞介导的细胞毒性。
J Immunol. 2024 Oct 15;213(8):1105-1114. doi: 10.4049/jimmunol.2400250.
9
Omicron BA.1-specific T-cell responses in adults vaccinated with CoronaVac or BNT162b2 in Hong Kong: an observational cohort study.奥密克戎 BA.1 特异性 T 细胞应答在香港接种科兴或辉瑞疫苗的成年人中的观察性队列研究。
Lancet Microbe. 2023 Jun;4(6):e418-e430. doi: 10.1016/S2666-5247(23)00006-X. Epub 2023 Apr 20.
10
Immune Responses After Vaccination With Primary 2-Dose ChAdOx1 Plus a Booster of BNT162b2 or Vaccination With Primary 2-Dose BNT162b2 Plus a Booster of BNT162b2 and the Occurrence of Omicron Breakthrough Infection.接种两剂腺病毒载体 ChAdOx1 加一剂 BNT162b2 加强针或接种两剂 BNT162b2 加一剂 BNT162b2 加强针后的免疫反应,以及奥密克戎突破性感染的发生。
J Korean Med Sci. 2023 May 22;38(20):e155. doi: 10.3346/jkms.2023.38.e155.

引用本文的文献

1
COVID-19 Vaccination Still Makes Sense: Insights on Pneumonia Risk and Hospitalization from a Large-Scale Study at an Academic Tertiary Center in Italy.新冠疫苗接种仍有意义:来自意大利一家学术三级中心的大规模研究对肺炎风险和住院情况的见解
Microorganisms. 2025 Jul 25;13(8):1744. doi: 10.3390/microorganisms13081744.
2
Long-Term Durability and Variant-Specific Modulation of SARS-CoV-2 Humoral and Cellular Immunity over Two Years.两年间 SARS-CoV-2 体液免疫和细胞免疫的长期持久性及变异株特异性调节
Int J Mol Sci. 2025 Aug 21;26(16):8106. doi: 10.3390/ijms26168106.
3
Immune Durability and Breakthrough Infections 15 Months After SARS-CoV-2 Boosters in People over 65: The IMMERSION Study.

本文引用的文献

1
Long-term systemic and mucosal SARS-CoV-2 IgA response and its association with persistent smell and taste disorders.长期系统性和黏膜 SARS-CoV-2 IgA 应答及其与持续性嗅觉和味觉障碍的关系。
Front Immunol. 2023 Mar 8;14:1140714. doi: 10.3389/fimmu.2023.1140714. eCollection 2023.
2
Modelling COVID-19 vaccine breakthrough infections in highly vaccinated Israel-The effects of waning immunity and third vaccination dose.以色列高疫苗接种率下新冠病毒疫苗突破性感染的建模——免疫力下降和第三次疫苗接种剂量的影响
PLOS Glob Public Health. 2022 Nov 9;2(11):e0001211. doi: 10.1371/journal.pgph.0001211. eCollection 2022.
3
Past SARS-CoV-2 infection protection against re-infection: a systematic review and meta-analysis.
65岁以上人群接种新冠病毒加强针15个月后的免疫持久性和突破性感染:IMMERSION研究
Vaccines (Basel). 2025 Jul 9;13(7):738. doi: 10.3390/vaccines13070738.
4
Immunogenicity of monovalent and multivalent subunit vaccines against SARS-CoV-2 variants in mice with divergent vaccination history.具有不同疫苗接种史的小鼠中,单价和多价亚单位疫苗针对新冠病毒变异株的免疫原性。
Microbiol Spectr. 2025 Jul 17:e0290724. doi: 10.1128/spectrum.02907-24.
5
A 22 month prospective assessment of neutralizing and IgG antibody levels against SARS-CoV-2 variants following homologous and heterologous BNT162b2 boosting.同源和异源BNT162b2加强免疫后针对SARS-CoV-2变异株的中和抗体和IgG抗体水平的22个月前瞻性评估。
Sci Rep. 2025 Jul 1;15(1):21175. doi: 10.1038/s41598-025-05377-3.
6
Use of a Multiplex Immunoassay Platform to Investigate Multifaceted Antibody Responses in SARS-CoV-2 Vaccinees with and Without Prior Infection.使用多重免疫分析平台研究有或无既往感染的新冠病毒疫苗接种者的多方面抗体反应。
COVID. 2025 Apr;5(4). doi: 10.3390/covid5040044. Epub 2025 Mar 22.
7
Multiple infections with Omicron variants increase breadth and potency of Omicron-specific neutralizing antibodies.感染多种奥密克戎变异株可增加奥密克戎特异性中和抗体的广度和效力。
Cell Discov. 2025 May 20;11(1):49. doi: 10.1038/s41421-025-00800-5.
8
Beyond the Pandemic Era: Recent Advances and Efficacy of SARS-CoV-2 Vaccines Against Emerging Variants of Concern.后疫情时代:SARS-CoV-2疫苗针对新出现的关注变异株的最新进展与效果
Vaccines (Basel). 2025 Apr 17;13(4):424. doi: 10.3390/vaccines13040424.
9
COVID-19 Reinfections in the City of São Paulo, Brazil: Prevalence and Socioeconomic Factors.巴西圣保罗市的新冠病毒再次感染情况:患病率及社会经济因素
Open Forum Infect Dis. 2025 Apr 16;12(4):ofaf181. doi: 10.1093/ofid/ofaf181. eCollection 2025 Apr.
10
JN.1 variants circulating in Italy from October 2023 to April 2024: genetic diversity and immune recognition.2023年10月至2024年4月在意大利流行的JN.1变体:遗传多样性和免疫识别
BMC Infect Dis. 2025 Feb 28;25(1):291. doi: 10.1186/s12879-025-10685-0.
既往 SARS-CoV-2 感染对再感染的保护作用:系统评价和荟萃分析。
Lancet. 2023 Mar 11;401(10379):833-842. doi: 10.1016/S0140-6736(22)02465-5. Epub 2023 Feb 16.
4
Pre-existing immunity modulates responses to mRNA boosters.预先存在的免疫会调节对 mRNA 加强针的反应。
Cell Rep. 2023 Mar 28;42(3):112167. doi: 10.1016/j.celrep.2023.112167. Epub 2023 Feb 15.
5
Impact of BNT162b2 Booster Dose on SARS-CoV-2 Anti-Trimeric Spike Antibody Dynamics in a Large Cohort of Italian Health Care Workers.BNT162b2加强剂量对一大群意大利医护人员中SARS-CoV-2抗三聚体刺突抗体动力学的影响
Vaccines (Basel). 2023 Feb 17;11(2):463. doi: 10.3390/vaccines11020463.
6
SARS-CoV-2 humoral and cellular immunity following different combinations of vaccination and breakthrough infection.不同疫苗接种和突破感染组合后 SARS-CoV-2 的体液和细胞免疫。
Nat Commun. 2023 Feb 2;14(1):572. doi: 10.1038/s41467-023-36250-4.
7
Hybrid Immunity More Protective Than Prior SARS-CoV-2 Infection Alone.混合免疫比单纯既往感染新冠病毒更具保护作用。
JAMA. 2023 Feb 21;329(7):531. doi: 10.1001/jama.2023.0743.
8
Immunogenicity of BA.5 Bivalent mRNA Vaccine Boosters.BA.5二价mRNA疫苗加强针的免疫原性。
N Engl J Med. 2023 Feb 9;388(6):565-567. doi: 10.1056/NEJMc2213948. Epub 2023 Jan 11.
9
Long-term durability of antibody responses after SARS-CoV-2 vaccination and influencing factors.SARS-CoV-2疫苗接种后抗体反应的长期持久性及影响因素。
J Intern Med. 2023 Apr;293(4):520-523. doi: 10.1111/joim.13601. Epub 2023 Jan 10.
10
Infectiousness of SARS-CoV-2 breakthrough infections and reinfections during the Omicron wave.奥密克戎变异株流行期间 SARS-CoV-2 突破性感染和再感染的传染性。
Nat Med. 2023 Feb;29(2):358-365. doi: 10.1038/s41591-022-02138-x. Epub 2023 Jan 2.